Arbutus Biopharma Corp (NASDAQ:ABUS) currently has a daily average trading volume of 1.02M but it saw 877722 shares traded in last market. With a market cap of 658.86M USD, the company’s current market price of $3.44 came rising about 0.88 while comparing to the previous closing price of $3.41. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.72 and as low as $2.70.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which upgraded the stock as “Buy” in its note to investors issued on February 02, 2022, recommending a price target of $5 for it. H.C. Wainwright issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, ABUS’s stock price is moving 8.52% up while it is 0.88% when we observe its performance for the past one month. Year-to-date it is 5.20% up and over the past year, the stock is showing an upside performance of 4.56%.
Currently, Arbutus Biopharma Corp’s total number of outstanding shares is 191.48M with 21.89% of that held by the insiders while 59.26% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -90.95% and return on equity (ROE) at -79.02%. Stock’s beta reads 1.24. Stock has a price to book (P/B) ratio of 8.32 while price to sale or P/S ratio amounts to 102.95. Its return on asset (ROA) is -57.29% on average.
